Bidhya Timilsina, M.D. Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 2605 Keiser Blvd, Reading, PA 19610 Phone: 610-375-4679 |
Gary M Lattin, MD Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 145 N 6th St, 1st Fl, Reading, PA 19601 Phone: 610-378-2440 Fax: 610-378-2441 |
News Archive
Life Technologies Corporation today announced that it is collaborating with the Translational Genomics Research Institute and US Oncology to sequence the genomes of 14 patients afflicted with triple negative breast cancer whose tumors have progressed despite multiple other therapies.
Tranzyme Pharma and Norgine B.V., have initiated dosing of ulimorelin in the first of two, Phase 3 pivotal studies - ULISES. Ulimorelin is Tranzyme's intravenous promotility agent in development for the management of postoperative ileus in hospital and acute care settings.
Icagen, Inc. today provided an update on its sodium channel program for pain and related disorders, which is being conducted in collaboration with Pfizer. As previously reported, the companies recently selected a candidate compound to advance into further clinical studies. Dosing of this candidate compound has now been initiated in a Phase I study in healthy volunteers.
NHS professionals at a North West trust have been shortlisted for the prestigious national Patient Safety Awards, following important work around rapid response for deteriorating patients.
› Verified 2 days ago